Group One Trading’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-179,500
| Closed | -$6.76M | – | 8871 |
|
|
2021
Q1 | $6.76M | Buy |
179,500
+135,700
| +310% | +$3.38M | 0.01% | 1248 |
|
|
2020
Q4 | $745K | Buy |
43,800
+40,800
| +1,360% | +$511K | ﹤0.01% | 2909 |
|
|
2020
Q3 | $14K | Buy |
+3,000
| New | +$15.2K | ﹤0.01% | 5305 |
|
|
2019
Q3 | – | Sell |
-8,000
| Closed | -$48K | – | 5775 |
|
|
2019
Q2 | $48K | Buy |
8,000
+5,200
| +186% | +$49.7K | ﹤0.01% | 3804 |
|
|
2019
Q1 | $38K | Hold |
2,800
| – | – | ﹤0.01% | 3708 |
|
|
2018
Q4 | $26K | Sell |
2,800
-15,700
| -85% | -$187K | ﹤0.01% | 3913 |
|
|
2018
Q3 | $258K | Sell |
18,500
-7,500
| -29% | -$112K | ﹤0.01% | 2827 |
|
|
2018
Q2 | $411K | Buy |
+26,000
| New | +$454K | ﹤0.01% | 2455 |
|
|
2018
Q1 | – | Sell |
-700
| Closed | -$15K | – | 5521 |
|
|
2017
Q4 | $15K | Hold |
700
| – | – | ﹤0.01% | 4263 |
|
|
2017
Q3 | $29K | Buy |
+700
| New | +$22K | ﹤0.01% | 3901 |
|
|
2016
Q2 | – | Sell |
-6,000
| Closed | -$244K | – | 5083 |
|
|
2016
Q1 | $244K | Sell |
6,000
-400
| -6% | -$13.7K | ﹤0.01% | 2196 |
|
|
2015
Q4 | $266K | Buy |
6,400
+5,600
| +700% | +$188K | ﹤0.01% | 2284 |
|
|
2015
Q3 | $12K | Buy |
+800
| New | +$17.2K | ﹤0.01% | 4243 |
|
Group One Trading's FPRX Position: Q1 2021 in Review
Group One Trading sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 4,786 shares — an estimated $119K sold.
Group One Trading first reported a position in FPRX in Q4 2015 and held it in 10 quarters. The position peaked at $363K in Q2 2018. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.
- Group One Trading reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
- Group One Trading sold 4,786 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $119K.
- Group One Trading first reported a position in Five Prime Therapeutics, Inc. in Q4 2015 and held it in 10 quarters.
- Group One Trading's Five Prime Therapeutics, Inc. position peaked at $363K in Q2 2018.
- 147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.
Based on Group One Trading's 13F filing for Q1 2021, filed 12 May 2021.